Company News »

Genocea to Present at the Cowen and Company 35th Annual Health Care Conference

Business Wire
Share on StockTwits
Published on

Genocea Biosciences, Inc. (NASDAQ:GNCA) , a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that Chip Clark, president and chief executive officer, will present a company overview at the upcoming Cowen and Company 35th Annual Health Care Conference. The presentation is scheduled for Wednesday, March 4, 2015 at 11:20 a.m. EST in Boston, MA.

A live webcast of the presentation can be accessed by visiting the “Events and Presentations” tab of the investor relations section of the Genocea website at A replay of the webcast will be archived for 30 days following the presentation.

About Genocea
Genocea is harnessing the power of T cell immunity to develop life-changing vaccines and immunotherapies. T cells are increasingly recognized as a critical element of protective immune responses to a wide range of diseases, but traditional discovery methods have proven unable to identify the targets of such protective immune response. Using ATLASTM, its proprietary technology platform, Genocea identifies these targets to potentially enable the rapid development of medicines to address critical patient needs. Genocea’s pipeline of novel clinical stage T cell-directed product candidates includes GEN-003 to treat genital herpes, GEN-004 to prevent infections caused by pneumococcus, and earlier-stage programs in chlamydia, HSV prophylaxis, malaria and cancer immunotherapies. For more information, please visit the Company’s website at

Share on StockTwits